. It is well known that there is an increase in the percentage of calcium in the bones with increasing age, but apart from this the analyses of bones in health and disease are very much alike. X-ray spectrography has shown that the apatite structure is maintained in health and disease and that hyperparathyroidism is the only condition in which an alteration has been detected.
Clinicians have long been familiar with diseases of the endocrine system in which alterations of bone shape occur, and chemical investigations have now shed some light on these conditions. Of all hormones the growth-promoting factor of the anterior pituitary gland is undoubtedly the most potent in inducing skeletal change. The pituitary may exert a direct control over bone growth and the effects of other hormones\p=m-\e.g. those of the thyroid and parathyroid glands and the gonads\p=m-\may have to be explained on the basis of their effects on the production of this growth-promoting factor. On the other hand, the converse may hold, viz. the action of the pituitary may be indirect.
While there is considerable quantitative information about the gross metabolic changes in bone disease, there is little or no information about the nature of the physicochemical alterations, if any, produced [Logan, 1940] . It is well known that there is an increase in the percentage of calcium in the bones with increasing age, but apart from this the analyses of bones in health and disease are very much alike. X-ray spectrography has shown that the apatite structure is maintained in health and disease and that hyperparathyroidism is the only condition in which an alteration has been detected.
We have shown already [Bell, Cuthbertson & Orr, 1941] that rats on a very low calcium intake produced very thin-walled bones, which were relatively weak, but in spite of this the bones were still of normal shape. Generalized calcium deficiency, therefore, does not appear to be the essential cause of deformity. Since this work showed that we now possess a satisfactory method of investigating bone strength it seemed to us of interest to apply it to the bones of animals which had been treated with various hormones and to inquire if this new technique would throw any light on the nature of the bony changes in diseases of the endocrine system.
METHODS
The animals used were white male rats. They were all fed on an adequate diet [Thomson, 1936] , and the hormones were administered either with the food in the case of the thyroid or injected subcutaneously in the case of the other hormones. The controls of the same age received no treatment except in the case of the control animals of the pituitary experiments which received thymus extract instead of pituitary extract. The methods of feeding and the methods of chemical analysis were exactly as we have described in our previous paper.
Measurement of bone strength
The methods employed to measure the strength of the bones have already been described in considerable detail [Bell et 
Oestradiol
The animals were given 0· 1 mg. of oestradiol dipropionate (Ovocyclin P, Ciba) at the beginning of the experiment and again 3 -weeks later. This can be considered a very large dose of oestrogenic material, since it has been shown by Miescher, Scholz & Tschopp [1938] that half this dose would produce an oestrus lasting 40 days in castrated female rats. Gardner & Pfeiffer [1938] found that endosteal bone nearly or completely replaced the marrow cavities of the femora of mice which had received 250 i.u., or more, of oestrogens weekly over long periods (about a year). (1), (2) and (3).) Oestradiol experiments It will be seen that we were unable to produce any considerable alteration in the size of the femora or their calcium content or in the total and percentage calcium in the carcass, nor were we able to reproduce the striking reduction of the marrow cavity described by Gardner & Pfeiffer [1938] . It may be either that rats are more resistant than mice to skeletal changes or that our experiments were not sufficiently prolonged. The bones of the oestradiol-treated animals were slightly stronger than those of the controls (see M and T), but this is completely accounted for by their slightly larger dimensions so that the actual quality of the bony material indicated by formulae (1), (2) and (3) is the same.
Parathyroid hormone
Parathyroid experiments Reynolds et al. [1938] found on X-ray analysis of the bone powder of their para¬ thyroid-treated animals a pattern differing slightly from that given by the controls, but they did not offer any interpretation of thè difference. It is rather surprising that there should be any changes in rat bones because these animals-judged by clinical and chemical tests-are almost immune to chronic high dosage of parathyroid hormone. Selye [1932] has drawn attention to the stimulating effect of this hormone on the formation of osteoblasts leading to bone apposition. Human beings are also fairly resistant to chronic high dosage, but in spite of this, changes have also been reported in the X-ray spectrogram in cases of hyperparathyroidism ].
There was a marked increase in the body weight of the parathyroid-hormonetreated animals as compared with the controls ; they were also slightly longer and had bigger and heavier femora indicating increased osteoblastic activity. The percentage of calcium in the femur was very little affected by parathyroid hormone treatment ; this was also the case in the experiments of Reynolds et al. [1938] . The total calcium of the carcass was higher than that of the controls although the percentage of calcium was, if anything, less ; thus while the hormone induced a greater deposition of bone there was a nearly equivalent addition of soft tissue.
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The femora of the parathyroid group were slightly stronger than those of the con¬ trols but since the dimensions of the former were proportionately greater the quality of the bone material in both groups is the same.
Thyroid experiments
The first experiment was the more severe ; the animals lost on the average 1-2 g./day as against 0-6 g. in the second experiment. In the first and shorter experiment the treated animals lost 13 % of their body weight as against 18 % in the second experi¬ ment which lasted more than two and a half times longer. The gain in weight of the control animals of the first experiment was 13%; the total body loss of the thyroidtreated animals was therefore of the order of 26%. There is thus no doubt that the dosage of thyroid was sufficient to produce a very profound disturbance of metabolism ; indeed in such a chronic experiment the dosage could not safely be increased. In these circumstances if skeletal changes accompany the hyperthyroid state then they cer¬ tainly should have appeared in our experiments.
The loss of skeletal calcium was not quite proportional to the general loss in body weight since the percentage of calcium in the thyroid carcasses was greater than in the controls. In the second more chronic experiment there was little difference in the percentage of calcium in the femur, but in the more severe first experiment there was a definite reduction. It is of interest that the skiagrams in group 1 showed no dif¬ ference between treated and control bones although there was a 13 % reduction in the calcium of the femora. This indicates that X-ray evidence is only of value after con¬ siderable résorption of bone has occurred.
The strength of the thyroid-treated bones was less in both experiments but in both cases the bones were reduced in size in all dimensions so that the quality of the bone material was the same in all animals.
CONCLUSIONS
In these experiments we have attempted to induce changes in the metabolism of bone by means of hormones. Certain quantitative changes in the strength of the bones have obviously resulted, but these can be practically completely accounted for by the alterations produced in the dimensions of the bones so that the actual quality, or breaking stress, is substantially the same as that of the controls.
This work offers no explanation of .the change of shape seen in bone diseases pro¬ duced by excessive action of certain hormones. Measurements of the deflexion of the centre of the femur during the bending tests were made on representative samples of all the groups (2 from the oestradiol group, 2 from the parathormone group, 2 from the thyroid group, 4 from the pituitary group and 10 from the corresponding controls). There was no difference between controls and treated bones ; in all cases the graph of deflexion against load was a straight line up to the breaking point exactly as in the graph already published. It may be wiser to seek the causes of the deformities which are seen clinically in terms of the reaction of the bony tissue to muscular pull or body weight-an abnormal variant of the normal modelling process-rather than in terms of a qualitative alteration of the osseous tissue.
The results described do not permit of any useful speculation with regard to the riddle of direct or indirect action of the pituitary hormone on bone growth. Indeed, 
